Start Date: 25/04/2016

End Date: 25/04/2016

Cost: 45-115

Venue: Royal Society of Medicine, London


Royal Society of Medicine

Contact Details:

Verity Cotton

Tel: 02072903947

Fax: 02072902989



This one day conference will update you on key developments in autosomal dominant polycystic kidney disease (ADPKD) through the review of clinical trials, novel therapies and disease progression tools. The meeting will look at ADPKD through the perspectives of different specialists, as well as review of the WGIKD summary, the TEMPO 3:4 Trial and who to treat with the Jinarc drug, which was recently recommended by NICE. The conference will include keynote lectures by Professor Yannick Le Meur from the Universite de Bretagne Occidentale, France, Professor Gerd Walz from the University Medical Centre Freiburg, Germany and Professor Olivier Devuyst from the University of Zurich, Switzerland. At the end of the meeting, attendees will have a better understanding of: The clinical overview of ADPKD How to monitor disease progression Recent reviews of clinical trials and novel therapies An overview of management and treatment for ADPKD The conference is most suitable for nephrologists, paediatricians, geneticists, nurses, members of the multi-disciplinary management team, scientists and patients, however all disciplines are welcome.